×

NPS Pharmaceuticals CEO on Gattex's FDA Approval

6:15 PM ET Mon, 7 Jan 2013

NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.